Ardelyx, Inc. (ARDX)Healthcare | Biotechnology | Waltham, United States | NasdaqGM
3.27 USD
+0.08
(2.508%)
⇧
(Oct. 15, 2026, 4 p.m.
EDT)
|
Hot Take ↕ | Oct. 10, 2026, 1:09 a.m. EDT
The investment case for Ardelyx is currently paralyzed by a disconnect between operational success and market pricing. While the company posted record revenue and profitability is described as 'right around the corner,' the stock has been decimated over the last decade, dropping nearly two-thirds from its peak. The balance sheet is fragile, with debt nearly matching cash reserves and negative operating cash flow, creating a precarious runway for a biotech firm. Although analysts see significant upside potential, the market has priced in a deep value trap or a failure to monetize its pipeline. The heavy put option activity confirms that investors are bracing for further pain rather than celebrating the recent sales growth. Until the path to profitability is clearly demonstrated and the debt burden is managed, the risk-reward profile remains skewed against the buyer. |
| Model | MAE |
|---|---|
| MSTL ✓ | 0.098379 |
| AutoTheta | 0.107990 |
| AutoETS | 0.108054 |
| AutoARIMA | 0.111787 |
Forecast horizon: 45 days | Selected: MSTL
| Forecast Reliability | |
|---|---|
| Score | 37% |
| H-stat | 28.96 |
| Ljung-Box p | 0.000 |
| Jarque-Bera p | 0.265 |
| Excess Kurtosis | -1.17 |
| Attribute | Value |
|---|---|
| Sector | Healthcare |
| Debt to Equity Ratio | 189.585 |
| Revenue per Share | 1.841 |
| Market Cap | 844,273,344 |
| Forward P/E | 11.26 |
| Beta | 0.68 |
| Profit Margins | -12.35% |
| Website | https://www.ardelyx.com |
As of Oct. 10, 2026, 1:09 a.m. EDT: Speculators are heavily positioned for downside protection, with massive open interest in out-of-the-money puts (strikes 4.0 and 6.0) relative to calls. This 'put skew' suggests a fear of further decline or a specific catalyst for a drop, despite the company reporting record revenue. The lack of significant call volume above current prices indicates a lack of immediate bullish conviction among retail traders.
| Attribute | Value |
|---|---|
| 52 Week Change | -0.36580515 |
| Address1 | 400 Fifth Avenue |
| Address2 | Suite 210 |
| All Time High | 35.48 |
| All Time Low | 0.49 |
| Ask | 6.45 |
| Ask Size | 2 |
| Audit Risk | 8 |
| Average Analyst Rating | 1.1 - Strong Buy |
| Average Daily Volume10 Day | 4,878,360 |
| Average Daily Volume3 Month | 4,321,414 |
| Average Volume | 4,321,414 |
| Average Volume10Days | 4,878,360 |
| Beta | 0.678 |
| Bid | 3.62 |
| Bid Size | 2 |
| Board Risk | 5 |
| Book Value | 0.598 |
| City | Waltham |
| Compensation As Of Epoch Date | 1,767,139,200 |
| Compensation Risk | 7 |
| Country | United States |
| Crypto Tradeable | 0 |
| Currency | USD |
| Current Price | 3.27 |
| Current Ratio | 3.342 |
| Custom Price Alert Confidence | HIGH |
| Date Short Interest | 1,790,726,400 |
| Day High | 3.345 |
| Day Low | 3.19 |
| Debt To Equity | 189.585 |
| Display Name | Ardelyx |
| Dividend Yield | 0.0 |
| Earnings Call Timestamp End | 1,786,048,200 |
| Earnings Call Timestamp Start | 1,786,048,200 |
| Earnings Timestamp | 1,786,046,400 |
| Earnings Timestamp End | 1,793,304,000 |
| Earnings Timestamp Start | 1,793,304,000 |
| Ebitda | -32,106,000 |
| Ebitda Margins | -0.07121 |
| Enterprise To Ebitda | -25.401 |
| Enterprise To Revenue | 1.809 |
| Enterprise Value | 815,520,384 |
| Eps Current Year | -0.18831 |
| Eps Forward | 0.29048 |
| Eps Trailing Twelve Months | -0.23 |
| Esg Populated | 0 |
| Exchange | NGM |
| Exchange Data Delayed By | 15 |
| Exchange Timezone Name | America/New_York |
| Exchange Timezone Short Name | EDT |
| Fifty Day Average | 3.6722 |
| Fifty Day Average Change | -0.40219998 |
| Fifty Day Average Change Percent | -0.10952562 |
| Fifty Two Week Change Percent | -36.580513 |
| Fifty Two Week High | 8.4 |
| Fifty Two Week High Change | -5.1299996 |
| Fifty Two Week High Change Percent | -0.61071426 |
| Fifty Two Week Low | 3.06 |
| Fifty Two Week Low Change | 0.21000004 |
| Fifty Two Week Low Change Percent | 0.06862746 |
| Fifty Two Week Range | 3.06 - 8.4 |
| Financial Currency | USD |
| First Trade Date Milliseconds | 1,403,184,600,000 |
| Float Shares | 210,663,173 |
| Forward Eps | 0.29048 |
| Forward P E | 11.25723 |
| Free Cashflow | 20,468,000 |
| Full Exchange Name | NasdaqGM |
| Full Time Employees | 489 |
| Fullday Change | 0.0 |
| Fullday Change Percent | 0.0 |
| Fullday Price | 3.27 |
| Gmt Off Set Milliseconds | -14,400,000 |
| Governance Epoch Date | 1,790,812,800 |
| Gross Margins | 0.75024 |
| Gross Profits | 338,279,008 |
| Has Pre Post Market Data | 1 |
| Held Percent Insiders | 0.030369999 |
| Held Percent Institutions | 0.73235 |
| Implied Shares Outstanding | 258,187,572 |
| Industry | Biotechnology |
| Industry Disp | Biotechnology |
| Industry Key | biotechnology |
| Is Earnings Date Estimate | 0 |
| Language | en-US |
| Last Fiscal Year End | 1,767,139,200 |
| Long Business Summary | Ardelyx, Inc. discovers, develops, and commercializes medicines to treat unmet medical needs in the United States and internationally. The company offers IBSRELA, a minimally absorbed small molecule therapy for the treatment of patients with irritable bowel syndrome with constipation; and XPHOZAH, a phosphate absorption inhibitor to reduce serum phosphorus in adults with chronic kidney disease on dialysis. Ardelyx, Inc. was formerly known as Nteryx, Inc. and changed its name to Ardelyx, Inc. in June 2008. The company was incorporated in 2007 and is headquartered in Waltham, Massachusetts. |
| Long Name | Ardelyx, Inc. |
| Market | us_market |
| Market Cap | 844,273,344 |
| Market State | PRE |
| Max Age | 86,400 |
| Message Board Id | finmb_58915635 |
| Most Recent Quarter | 1,782,777,600 |
| Net Income To Common | -55,702,000 |
| Next Fiscal Year End | 1,798,675,200 |
| Non Diluted Market Cap | 897,201,812 |
| Number Of Analyst Opinions | 10 |
| Open | 3.24 |
| Operating Cashflow | -17,320,000 |
| Operating Margins | -0.102790006 |
| Overall Risk | 7 |
| Phone | 510 745 1700 |
| Pre Market Change | 0.0 |
| Pre Market Change Percent | 0.0 |
| Pre Market Price | 3.27 |
| Pre Market Time | 1,792,147,035 |
| Previous Close | 3.19 |
| Price Eps Current Year | -17.364983 |
| Price Hint | 4 |
| Price To Book | 5.4682274 |
| Price To Sales Trailing12 Months | 1.872443 |
| Profit Margins | -0.12354 |
| Quick Ratio | 2.891 |
| Quote Source Name | Nasdaq Real Time Price |
| Quote Type | EQUITY |
| Recommendation Key | strong_buy |
| Recommendation Mean | 1.09091 |
| Region | US |
| Regular Market Change | 0.0799999 |
| Regular Market Change Percent | 2.50783 |
| Regular Market Day High | 3.345 |
| Regular Market Day Low | 3.19 |
| Regular Market Day Range | 3.19 - 3.345 |
| Regular Market Open | 3.24 |
| Regular Market Previous Close | 3.19 |
| Regular Market Price | 3.27 |
| Regular Market Time | 1,792,094,401 |
| Regular Market Volume | 4,065,838 |
| Return On Assets | -0.0425 |
| Return On Equity | -0.38609 |
| Revenue Growth | 0.238 |
| Revenue Per Share | 1.841 |
| Sand P52 Week Change | 0.16207206 |
| Sector | Healthcare |
| Sector Disp | Healthcare |
| Sector Key | healthcare |
| Share Holder Rights Risk | 8 |
| Shares Outstanding | 258,187,572 |
| Shares Percent Shares Out | 0.107200004 |
| Shares Short | 27,676,626 |
| Shares Short Previous Month Date | 1,788,134,400 |
| Shares Short Prior Month | 22,716,201 |
| Short Name | Ardelyx, Inc. |
| Short Percent Of Float | 0.1095 |
| Short Ratio | 6.68 |
| Source Interval | 15 |
| State | MA |
| Symbol | ARDX |
| Target High Price | 18.0 |
| Target Low Price | 8.0 |
| Target Mean Price | 12.9 |
| Target Median Price | 13.5 |
| Total Cash | 281,830,016 |
| Total Cash Per Share | 1.131 |
| Total Debt | 282,507,008 |
| Total Revenue | 450,894,016 |
| Tradeable | 0 |
| Trailing Annual Dividend Rate | 0.0 |
| Trailing Annual Dividend Yield | 0.0 |
| Trailing Eps | -0.23 |
| Trailing Peg Ratio | None |
| Triggerable | 1 |
| Two Hundred Day Average | 5.533625 |
| Two Hundred Day Average Change | -2.2636251 |
| Two Hundred Day Average Change Percent | -0.4090673 |
| Type Disp | Equity |
| Volume | 4,065,838 |
| Website | https://www.ardelyx.com |
| Zip | 2,451 |